The Food and Drug Administration (FDA) has approved Isturisa ® (osilodrostat) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery is not an option or has ...

Furthermore, erdosteine has shown a synergism with antibiotic therapy. In stable COPD patients, long-term treatment with erdosteine had a protective effect against exacerbations by reducing the ...

Some gut–brain neuromodulators are efficacious in reducing global symptoms and abdominal pain in IBS. The findings support ...

bDepartment of Medicine, Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, and Department of Anesthesia, University of California, San Francisco, CA, USA cWellcome-Wolfson Institute ...